148 related articles for article (PubMed ID: 6383207)
1. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
Bailey JM; Heppleston C; Richmond SJ
Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
[TBL] [Abstract][Full Text] [Related]
2. Antichlamydial activity of ofloxacin.
Hirai K; Une T
Microbiol Immunol; 1986; 30(5):445-50. PubMed ID: 3462450
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
Madhavan HN; Roy S; Malathy J
Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.
Stamm WE; Suchland R
Antimicrob Agents Chemother; 1986 Nov; 30(5):806-7. PubMed ID: 3467650
[TBL] [Abstract][Full Text] [Related]
5. Activity of ofloxacin against Chlamydia trachomatis.
Møller BR; Evans R; Kaspersen P; From E
Drugs; 1987; 34 Suppl 1():181-3. PubMed ID: 3481321
[No Abstract] [Full Text] [Related]
6. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
Welsh LE; Gaydos CA; Quinn TC
Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
[TBL] [Abstract][Full Text] [Related]
8. [Activity of a new quinoline derivative against Chlamydia trachomatis].
Mitsui Y; Higashitsutsumi M
Nippon Ganka Gakkai Zasshi; 1986 Aug; 90(8):1074-80. PubMed ID: 3464167
[No Abstract] [Full Text] [Related]
9. In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
Meier-Ewert H; Weil G; Millott G
Eur J Clin Microbiol; 1984 Aug; 3(4):372. PubMed ID: 6593220
[No Abstract] [Full Text] [Related]
10. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).
Lefèvre JC; Lépargneur JP
Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914
[TBL] [Abstract][Full Text] [Related]
12. [In vitro inhibition of Chlamydia trachomatis growth by liposome-encapsulated cyclines].
Sangaré L; Morisset R; Ravaoarinoro M
Pathol Biol (Paris); 2001 Feb; 49(1):53-6. PubMed ID: 11265224
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain.
How SJ; Hobson D; Hart CA; Quayle E
J Antimicrob Chemother; 1985 Apr; 15(4):399-404. PubMed ID: 3891709
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
Walsh M; Kappus EW; Quinn TC
Antimicrob Agents Chemother; 1987 May; 31(5):811-2. PubMed ID: 3038010
[TBL] [Abstract][Full Text] [Related]
15. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Hartinger A; Korting HC; Neubert U; Blaufuss H
Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
[TBL] [Abstract][Full Text] [Related]
17. Antichlamydial activity of quinolone carboxylic acids.
Heppleston C; Richmond S; Bailey J
J Antimicrob Chemother; 1985 May; 15(5):645-7. PubMed ID: 3159713
[No Abstract] [Full Text] [Related]
18. [In vitro sensitivity of Chlamydiae to antibiotics].
Dailloux M; Ottemer C; Albert H; Weber M
Pathol Biol (Paris); 1990 May; 38(5):426-30. PubMed ID: 2195451
[TBL] [Abstract][Full Text] [Related]
19. Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis.
Webberley JM; Matthews RS; Andrews JM; Wise R
Eur J Clin Microbiol; 1987 Oct; 6(5):587-9. PubMed ID: 2449348
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
